N6-Cyclopentyladenosine

Modify Date: 2024-01-02 11:28:59

N6-Cyclopentyladenosine Structure
N6-Cyclopentyladenosine structure
Common Name N6-Cyclopentyladenosine
CAS Number 41552-82-3 Molecular Weight 335.36
Density 1.78g/cm3 Boiling Point 673.4ºC at 760 mmHg
Molecular Formula C15H21N5O4 Melting Point N/A
MSDS USA Flash Point 361.1ºC

 Use of N6-Cyclopentyladenosine


N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively[1][2].

 Names

Name (2R,3R,4S,5R)-2-(6-(Cyclopentylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
Synonym More Synonyms

 N6-Cyclopentyladenosine Biological Activity

Description N6-Cyclopentyladenosine (CPA) is a selective Adenosine A1 receptor agonist, with Ki values of 2.3 nM, 790 nM and 43 nM for human A1, A2A and A3 receptors, respectively[1][2].
Related Catalog
Target

Ki: 2.3 nM (A1), 790 nM (A2A), 43 nM(A3)[1].

References

[1]. Klotz KN, et al. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):382-91.

[2]. Soliño M, et al. Adenosine A1 receptor: A neuroprotective target in light induced retinal degeneration. PLoS One. 2018 Jun 18;13(6):e0198838.

 Chemical & Physical Properties

Density 1.78g/cm3
Boiling Point 673.4ºC at 760 mmHg
Molecular Formula C15H21N5O4
Molecular Weight 335.36
Flash Point 361.1ºC
Exact Mass 335.15900
PSA 125.55000
Index of Refraction 1.816
Storage condition 2-8℃

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR NONH for all modes of transport

 Synthetic Route

~79%

N6-Cyclopentyladenosine Structure

N6-Cyclopentyla...

CAS#:41552-82-3

Literature: Ottria, Roberta; Casati, Silvana; Baldoli, Erika; Maier, Jeanette A.M.; Ciuffreda, Pierangela Bioorganic and Medicinal Chemistry, 2010 , vol. 18, # 23 p. 8396 - 8402

~70%

N6-Cyclopentyladenosine Structure

N6-Cyclopentyla...

CAS#:41552-82-3

Literature: Vittori, Sauro; Lorenzen, Anna; Stannek, Christina; Costanzi, Stefano; Volpini, Rosaria; Ijzerman, Adriaan P.; Von Frijtag Drabbe Kunzel, Jakobien K.; Cristalli, Gloria Journal of Medicinal Chemistry, 2000 , vol. 43, # 2 p. 250 - 260

~85%

N6-Cyclopentyladenosine Structure

N6-Cyclopentyla...

CAS#:41552-82-3

Literature: Fletcher, Steven Tetrahedron Letters, 2010 , vol. 51, # 22 p. 2948 - 2950

~%

N6-Cyclopentyladenosine Structure

N6-Cyclopentyla...

CAS#:41552-82-3

Literature: Vittori, Sauro; Lorenzen, Anna; Stannek, Christina; Costanzi, Stefano; Volpini, Rosaria; Ijzerman, Adriaan P.; Von Frijtag Drabbe Kunzel, Jakobien K.; Cristalli, Gloria Journal of Medicinal Chemistry, 2000 , vol. 43, # 2 p. 250 - 260

~%

N6-Cyclopentyladenosine Structure

N6-Cyclopentyla...

CAS#:41552-82-3

Literature: Vittori, Sauro; Lorenzen, Anna; Stannek, Christina; Costanzi, Stefano; Volpini, Rosaria; Ijzerman, Adriaan P.; Von Frijtag Drabbe Kunzel, Jakobien K.; Cristalli, Gloria Journal of Medicinal Chemistry, 2000 , vol. 43, # 2 p. 250 - 260

~%

N6-Cyclopentyladenosine Structure

N6-Cyclopentyla...

CAS#:41552-82-3

Literature: Inotek Pharmaceuticals Corporation Patent: US2007/238694 A1, 2007 ; Location in patent: Page/Page column 130 ;

 Articles115

More Articles
The effect of pH and ion channel modulators on human placental arteries.

PLoS ONE 9(12) , e114405, (2014)

Chorionic plate arteries (CPA) are located at the maternofetal interface where they are able to respond to local metabolic changes. Unlike many other types of vasculature, the placenta lacks nervous c...

Acid-sensing ion channel 3 decreases phosphorylation of extracellular signal-regulated kinases and induces synoviocyte cell death by increasing intracellular calcium.

Arthritis. Res. Ther. 16(3) , R121, (2014)

Acid-sensing ion channel 3 (ASIC3) is expressed in synoviocytes, activated by decreases in pH, and reduces inflammation in animal models of inflammatory arthritis. The purpose of the current study was...

Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.

Chemistry 21 , 10903-12, (2015)

A fast chemoenzymatic synthesis of sialylated oligosaccharides containing C5-modified neuraminic acids is reported. Analogues of GM3 and GM2 ganglioside saccharidic portions where the acetyl group of ...

 Synonyms

N6-Cyclopentyladenosine